Press Releases

08.03.2022
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022
08.02.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07.26.2022
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
07.26.2022
Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank
07.21.2022
Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022
07.16.2022
Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting
07.05.2022
Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®
07.01.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06.10.2022
Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
06.02.2022
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)